Anti-Aging Ultra Cream

Anti-Aging Ultra Cream is a compounded, prescription-only dermatologic preparation designed to address multiple biochemical pathways implicated in cutaneous aging. Each 30-gram cream delivers a precisely balanced concentration of five active ingredients-10 % ascorbic acid, 5 % azelaic acid, 1 % alpha-lipoic acid, 0.1 % estriol, and 2 % progesterone-within an anhydrous base optimized for dermal penetration. Topical ascorbic acid has demonstrated clinically significant improvement in photodamaged skin texture and collagen architecture when compared with placebo, validating its role as the keystone antioxidant in the formulation. [1] Estriol, a weaker estrogen with predominantly cutaneous activity, has separately been shown to improve elasticity and diminish wrinkle depth in perimenopausal women, supporting its inclusion as a hormonal rejuvenant. [2]

Beyond single-agent effects, the cream leverages synergistic mechanisms. Azelaic acid contributes antimicrobial and anti-inflammatory benefits that complement the free-radical scavenging of ascorbic acid while alpha-lipoic acid enhances intracellular recycling of oxidized antioxidants, sustaining redox balance and supporting extracellular matrix integrity. [3] [4] These combined actions aim to mitigate intrinsic collagen degradation, uneven pigmentation, and barrier dysfunction common to aging skin.

The vehicle is compounded exclusively in a 503A pharmacy, permitting patient-specific customization under a physician’s order and adherence to USP <795> and <800> guidelines. Because the preparation contains bio-identical sex steroids, counseling emphasizes that systemic absorption, although minimal, may still occur, particularly with prolonged or occlusive use. Patients with hormone-sensitive conditions therefore require individualized risk-benefit assessment and periodic monitoring. [5]

Ascorbic acid functions as a co-factor for prolyl and lysyl hydroxylases, stabilizing the triple helix of newly synthesized collagen and directly neutralizing reactive oxygen species (ROS) generated by ultraviolet radiation. A systematic review confirms its capacity to up-regulate type I and III collagen gene expression while simultaneously inhibiting melanogenesis, accounting for improvements in firmness and dyspigmentation. [6]

Azelaic acid, a dicarboxylic acid produced by Malassezia furfur, competitively inhibits tyrosinase and mitochondrial oxidoreductases, thereby reducing abnormal melanocyte activity and ROS formation. Its documented suppression of neutrophil-derived ROS explains clinical reductions in erythema and papulopustular lesions associated with both acne and rosacea. [3] [7] Retinoid-combination studies further indicate additive depigmenting benefits without significant irritation in skin of color, underscoring its versatility in multi-ingredient protocols. [8]

Ascorbic acid functions as a co-factor for prolyl and lysyl hydroxylases, stabilizing the triple helix of newly synthesized collagen and directly neutralizing reactive oxygen species (ROS) generated by ultraviolet radiation. A systematic review confirms its capacity to up-regulate type I and III collagen gene expression while simultaneously inhibiting melanogenesis, accounting for improvements in firmness and dyspigmentation. [6]

Azelaic acid, a dicarboxylic acid produced by Malassezia furfur, competitively inhibits tyrosinase and mitochondrial oxidoreductases, thereby reducing abnormal melanocyte activity and ROS formation. Its documented suppression of neutrophil-derived ROS explains clinical reductions in erythema and papulopustular lesions associated with both acne and rosacea. [3] [7] Retinoid-combination studies further indicate additive depigmenting benefits without significant irritation in skin of color, underscoring its versatility in multi-ingredient protocols. [8]

Alpha-lipoic acid is a potent, low-molecular-weight dithiol capable of shuttling between oxidized and reduced states, regenerating vitamins C and E in situ and modulating nuclear factor erythroid-2-related factor 2 (Nrf2) signaling. In skin-on-a-chip models, ALA increased filaggrin and involucrin expression and thickened epidermal equivalents, suggesting barrier normalization. [4] Supplementation studies corroborate enhancements in dermal microcirculation and sensory function, relevant to age-related perfusion decline. [9]

Estriol and progesterone act on estrogen and progesterone receptors within keratinocytes and fibroblasts. Topical estriol up-regulates hyaluronan synthase and type I procollagen while down-regulating matrix metalloproteinase-1, translating to measurable gains in skin turgor and moisture. [10] Progesterone augments dermal elastin content and suppresses inflammatory cytokines, effects observed with a 2 % cream in peri- and postmenopausal cohorts. [5] Together they may restore the hormone-responsive genomic milieu that wanes after midlife.

Use is contraindicated in patients with known hypersensitivity to any component of the formulation or with a history of severe contact dermatitis to topical acids or lipophilic antioxidants. Individuals with active or past estrogen- or progesterone-dependent neoplasms should avoid exposure given the presence of sex steroids. [10] [11]

Additional caution is advised in patients receiving systemic CYP3A4-inducing medications-such as certain anticonvulsants or rifampin-which can accelerate progesterone metabolism and alter hormonal balance. [12] Liver dysfunction may further modify steroid clearance, warranting physician oversight.

Concurrent application of strong oxidizers (e.g., benzoyl peroxide) can inactivate ascorbic acid; therefore, co-administration on the same skin site or routine is ill-advised. [13] Active facial dermatoses characterized by barrier disruption, including acute eczema or open lesions, increase the risk of systemic absorption and irritation and should be stabilized before treatment.

Topical vitamin C is readily oxidized by benzoyl peroxide; alternating morning vitamin C and evening peroxide minimizes mutual degradation. [13] Similarly, acidic alpha-hydroxy or beta-hydroxy exfoliants can lower the pH excessively and potentiate irritation, suggesting staggered scheduling or reduced frequency.

Azelaic acid pairs safely with retinoids, and combined regimens improve post-inflammatory hyperpigmentation without heightened irritation, yet simultaneous layering may still provoke transient stinging in sensitive users. [8] Close monitoring during initiation is prudent.

Systemic inducers of CYP3A4 may decrease local progesterone levels, theoretically reducing efficacy and altering systemic hormone ratios; conversely, potent inhibitors could heighten exposure. Although percutaneous absorption is low, clinicians should review medication profiles, particularly in polypharmacy populations. [15]

The most common reactions are mild, transient erythema, tingling, or dryness at the application site, attributable to the acidic pH and keratolytic nature of ascorbic and azelaic acids. [6] Patch testing or gradual titration mitigates early discomfort.

Azelaic acid has been associated with temporary pruritus or burning, described as self-limiting and rarely leading to discontinuation. [3] Alpha-lipoic acid may cause a subtle sulphurous odor on skin but demonstrates an excellent irritation profile in vitro and in vivo. [4]

Hormonal components introduce theoretical risks of systemic effects such as breast tenderness or menstrual irregularity, though randomized trials of 2 % progesterone cream reported no significant endocrine adverse events relative to vehicle and pharmacovigilance databases list few cutaneous events. Nonetheless, unexpected systemic symptoms warrant cessation and evaluation. [5] [11]

Sufficient human data are lacking to confirm safety of topical estriol or progesterone during pregnancy; therefore, the preparation is not recommended for pregnant or nursing individuals. [10] Systemic absorption, while minimal, could theoretically influence fetal development or lactation. Patients planning conception should discontinue use and consult obstetric providers.

Azelaic acid is classified as pregnancy category B when used as a monotherapy, yet its co-formulation with hormones introduces additional uncertainty. Alpha-lipoic and ascorbic acids are generally regarded as safe antioxidants, but their inclusion does not offset hormonal considerations. Risk-benefit analysis must prioritize fetal safety over cosmetic benefit. [15]

For postpartum individuals not breastfeeding, therapy may resume once hormone levels normalize and wound integrity is restored, provided no contraindications exist. Clinical reassessment ensures suitability and adjusts expectations given hormonally induced skin changes during pregnancy. [6]

Store below 25 °C (77 °F) in a tightly closed, opaque container to protect the oxidation-sensitive antioxidants. [6]

Keep away from direct light and humidity, and do not freeze. Discard any product exhibiting darkening or separation, as this indicates degradation and possible loss of efficacy. [5]

1. Humbert, P. G., Haftek, M., Creidi, P., et al. (2003). Topical ascorbic acid on photoaged skin: Clinical, topographical and ultrastructural evaluation-double-blind study vs. placebo. Experimental Dermatology, 12(3), 237-244. [https://doi.org/10.1034/j.1600-0625.2003.00008.x\\

\- Link Opens in New Tab](https://doi.org/10.1034/j.1600-0625.2003.00008.x)

2. Schmidt, J. B., Binder, M., Macheiner, W., et al. (1994). Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds: A pilot study. Maturitas, 20(1), 25-30. [https://doi.org/10.1016/0378-5122(94)90097-3\\

\- Link Opens in New Tab](https://doi.org/10.1016/0378-5122(94)90097-3)

3. Sauer, N., Oślizło, M., Brzostek, M., et al. (2024). The multiple uses of azelaic acid in dermatology: Mechanism of action, preparations, and potential therapeutic applications. Postępy Dermatologii i Alergologii, 40(6), 716-724. [https://doi.org/10.5114/ada.2023.133955\\

\- Link Opens in New Tab](https://doi.org/10.5114/ada.2023.133955)

4. Kim, K., Kim, J., Kim, H., et al. (2021). Effect of α-lipoic acid on the development of human skin equivalents using a pumpless skin-on-a-chip model. International Journal of Molecular Sciences, 22(4), 2160. [https://doi.org/10.3390/ijms22042160\\

\- Link Opens in New Tab](https://doi.org/10.3390/ijms22042160)

5. Holzer, G., Riegler, E., Hönigsmann, H., et al. (2005). Effects and side-effects of 2 % progesterone cream on the skin of peri- and postmenopausal women: Results from a double-blind, vehicle-controlled, randomized study. British Journal of Dermatology, 153(3), 626-634. [https://doi.org/10.1111/j.1365-2133.2005.06685.x\\

\- Link Opens in New Tab](https://doi.org/10.1111/j.1365-2133.2005.06685.x)

6. Klimek, P., Bodkhe, R., Łoś-Kaszczyńska, K., et al. (2024). Ascorbic acid treatments as effective and safe anti-aging therapies for sensitive skin. Antioxidants, 13(2), 174. [https://doi.org/10.3390/antiox13020174\\

\- Link Opens in New Tab](https://doi.org/10.3390/antiox13020174)

7. Jones, D. A. (2009). Rosacea, reactive oxygen species, and azelaic acid. Journal of Clinical and Aesthetic Dermatology, 2(1), 26-30. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958186/\\

\- Link Opens in New Tab](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958186/)

8. Woolery-Lloyd, H. C., Keri, J., & Doig, S. (2013). Retinoids and azelaic acid to treat acne and hyperpigmentation in skin of color. Journal of Drugs in Dermatology, 12(4), 434-437. [https://jddonline.com/articles/retinoids-and-azelaic-acid-to-treat-acne-and-hyperpigmentation-in-skin-of-color-S1545961613P0434X\\

\- Link Opens in New Tab](https://jddonline.com/articles/retinoids-and-azelaic-acid-to-treat-acne-and-hyperpigmentation-in-skin-of-color-S1545961613P0434X)

9. .de Bengy, A.-F., Decorps, J., Martin, L. S., et al. (2022). Alpha-lipoic acid supplementation restores early age-related sensory and endothelial dysfunction in the skin. Biomedicines, 10(11), 2887. [https://doi.org/10.3390/biomedicines10112887\\

\- Link Opens in New Tab](https://doi.org/10.3390/biomedicines10112887)

10. Schmidt, J. B., Hönigsmann, H., & Bieglmayer, C. (1996). Treatment of skin aging with topical estrogens. Archives of Dermatology, 132(1), 27-31. [https://doi.org/10.1001/archderm.1996.03890370033011\\

\- Link Opens in New Tab](https://doi.org/10.1001/archderm.1996.03890370033011)

11. DrugBank. (2025). Progesterone: Uses, interactions, mechanism of action. [https://go.drugbank.com/drugs/DB00396\\

\- Link Opens in New Tab](https://go.drugbank.com/drugs/DB00396)

12. Dapito, M. M., & Gomez, A. (2013). Isoform-specific regulation of cytochromes P450 expression by estrogens and progesterone. Toxicological Sciences, 135(3), 651-663. [https://doi.org/10.1093/toxsci/kft162\\

\- Link Opens in New Tab](https://doi.org/10.1093/toxsci/kft162)

13. Software. (2022). The dos and don’ts of mixing skincare ingredients. [https://www.skin.software/journal/skincare-ingredients-that-dont-mix\\

\- Link Opens in New Tab](https://www.skin.software/journal/skincare-ingredients-that-dont-mix)

14. Widjaja, A., Lim, J., & Seo, K. (2021). Clinical comparison of topical 2.5 % benzoyl peroxide plus 5 % niacinamide versus 2.5 % benzoyl peroxide alone for mild to moderate acne. Dermatology Research and Practice, 2021, 8857423. [https://doi.org/10.1155/2021/8857423\\

\- Link Opens in New Tab](https://doi.org/10.1155/2021/8857423)

15. Drugs..com. (2025). Drug interaction report: Estrogens/progestins with CYP3A4 inducers. [https://www.drugs.com/interactions-check.php\\

\- Link Opens in New Tab](https://www.drugs.com/interactions-check.php)

This compounded medication is prepared under section 503A of the U.S. Federal Food, Drug, and Cosmetic Act. Safety and efficacy for this formulation have not been evaluated by the FDA. Therapy should be initiated and monitored only by qualified healthcare professionals.